Owlstone Medical has announced the publication of a peer-reviewed study that identifies a set of volatile organic compounds that can identify patients with liver disease and separate them based on severity.

Mettler-Toledo Product Inspection will bring a message of productivity and integration to the Interpack trade fair in May 2023.

Ubiquigent Limited has announced it is supporting a Master’s student at the University of Glasgow to undertake a research project on USP30, a deubiquitinase implicated in neurodegenerative, renal and cardiovascular diseases.

The U.S. Food and Drug Administration and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ Multi-organ System.

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.

Optibrium has announced the appointment of Steve Yemm as Chief Commercial Officer.

Pheno Therapeutics Limited has announced that it has entered into an exclusive worldwide license agreement with UCB.

Aseptika, a UK company that specializes in making smart inhalers for patients with chronic respiratory conditions, has been co-funded by the UK’s Innovation Agency, Innovate UK.

Biosero, Inc. and DeepCure have announced their collaboration on an advanced, fully automated chemistry synthesis platform to accelerate drug discovery.

CN Bio has announced the appointment of Dr Paul Brooks, formerly the Company’s Chief Business Officer, to the position of CEO with immediate effect.